Your browser doesn't support javascript.
loading
Preservation of ovarian function.
Fabbri, R; Pasquinelli, G; Magnani, V; Tamburini, F; Battaglia, C; Paradisi, R; Keane, D; Venturoli, S.
Affiliation
  • Fabbri R; Human Reproductive Medicine Unit, Obstetrics and Gynaecology, S.Orsola Hospital, Bologna, Italy. raffaella.fabbri@unibo.it
Minerva Ginecol ; 62(3): 237-52, 2010 Jun.
Article in En | MEDLINE | ID: mdl-20595948
In the last years, advances in diagnosis and new treatments of cancer patient have increased the life expectancy of children, adolescent and women with cancer. Unfortunately, the ovaries are very sensitive to chemio-radiotherapy that may induce the loss of ovarian function and fertility with consequent premature ovarian failure. The different cryopreservation options available for fertility preservation in cancer patients are embryo cryopreservation, oocyte cryopreservation and ovarian tissue cryopreservation. The choice depends on different parameters: the type and timing of cancer treatment, the type of disease, the patient's age. The advances in reproductive technology have made fertility preservation a real possibility for patients whether they are girls or young women whose gonadal function is threatened by natural premature menopause, or by cancer therapy or surgical sterilisation.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Oocytes / Ovary / Cryopreservation / Fertility / Fetus Limits: Female / Humans Language: En Journal: Minerva Ginecol Year: 2010 Document type: Article Affiliation country: Italy Country of publication: Italy
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Oocytes / Ovary / Cryopreservation / Fertility / Fetus Limits: Female / Humans Language: En Journal: Minerva Ginecol Year: 2010 Document type: Article Affiliation country: Italy Country of publication: Italy